Trial
NCT03922139
Botox for the Treatment of Chronic Exertional Compartment Syndrome
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Wisconsin, Madison
Collaborators
—
Condition
Compartment Syndrome of Leg
Intervention
OnabotulinumtoxinA Injection
Why stopped
due to COVID-19
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-14